Options: Hide MedDRA Preferred Terms
MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels | |||
---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | ||||
Xerosis | Xerosis | 1% - 9% | x | x | x | ||
Paraesthesia | Tingling sensation | 1% - 29% | x | x | x | x | |
Pruritus | Pruritus | 0% - 11% | x | x | x | x | |
Dry skin | Dry skin | 1% - 9% | x | x | x | ||
Pain | Stinging | 1% - 16% | x | x | x | x | |
Erythema | Erythema | 1% - 2% | x | x | |||
Redness | x | x | x | ||||
Dermatitis contact | Dermatitis contact | 0% - 1% | x | x | x | x | |
Oedema | Oedema | 0% - 1% | x | x | x | ||
Acne | Acne | 0% - 1% | x | x | x | ||
Iridocyclitis | Iridocyclitis | postmarketing | x | x | x | ||
Asthma | Asthma | x | x | x | x | ||
Dermatitis | Dermatitis | x | |||||
Rash | x | ||||||
Rash | Rash | x | |||||
Oral herpes | Herpes labialis | x | x | x | x | ||
Hypersensitivity | Hypersensitivity | x | |||||
Hypertrichosis | Hypertrichosis | x | x | x | x | ||
Vitiligo | Vitiligo | x | x | x | x | ||
Application site reaction | Application site reaction | x | x | x | |||
Leukoderma | Leukoderma | x | x | x | x | ||
Keratosis pilaris | Keratosis pilaris | x | x | x | x | ||
Skin exfoliation | Localized exfoliation | x | |||||
Photosensitivity reaction | Phototoxicity | x | x | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |